Elsa Renee Flores
@LabElsaFlores
Moffitt Cancer Center ACD & Division Chief, Basic Science. Cancer Biologist. Discovery Science.
Happening now at #AACR25 👇
Happening in just over 30 mins our #AACR25 Major Symposium - Adaptive Therapy from Board to Bench to Bedside and Back Again. Come to room S103 at 12:30 to hear from me, Michelle Lockley & Carlo Maley eppro02.ativ.me/appinfo.php?pa… #MoffittAACR25
Super excited to share our newest piece out today @NatureRevCancer linking age-induced metabolic reprogramming to cancer development. nature.com/articles/s4156…
So exciting to be an integral part of the project! Can’t wait to tour the Moffitt Discovery & Innovation Center with you when we are open for science!@PatrickHwuMD @MoffittNews COO Sabi Singh @Timadams2023 @LeeMoffitt
Today I toured our #SperosFL campus under construction in Pasco County alongside @MoffittNews COO Sabi Singh and Board Chair Tim Adams. Incredible to see the progress and vision coming to life, from the Discovery & Innovation Center to the Speros Outpatient Center and the Richard…
Fabulous and inspiring scientist and mentor @DrJamesMule !
🚨 New episode of #TheImmunoVerse podcast is live! I had the honor of speaking with @DrJamesMule, a true pioneer in cell therapy and cancer immunology @MoffittNews. In this episode, he talks about carrying immunotherapy, particularly T cell therapy, from skepticism to standard…
I had the privilege of showing off the progress of the Moffitt Discovery and Innovation Center at SPEROS FL to a group of pioneering faculty. It’s been a real labor of love! Thank you to TKD, Whiting Turner, and Hammes for bringing the vision to life! Can’t wait to make new…




🚨Breaking Science from #ASCO25. Kenneth Tsai, MD, PhD, (@KYTsaiLab) joined us to discuss new data from the C-POST trial on adjuvant cemiplimab for patients with high-risk cutaneous squamous cell carcinoma. Details ⬇️ Read more: meetings.asco.org/abstracts-pres… #MoffittASCO25 @ASCO
Live from #ASCO25, Eric Haura, MD joined me at the @MoffittNews booth to discuss what he's most excited about at this year's annual meeting, including the evolution of RAS inhibitors—a class of targeted therapies designed to block the activity of RAS proteins, which are among the…
Exciting times for Moffitt and our Discovery and Innovation Center opening June 2026! Honored to be leading this effort for the SPEROS FL biotech hub!
The newly appointed president of Speros discusses strategies for uniting clinical expertise, research and commercial interests at Moffitt's expansive new campus. bizjournals.com/tampabay/news/…
Last night at #ASCO25, we celebrated the outstanding work of our Moffitt researchers and connected with industry partners driving progress in cancer research and care. Thank you to everyone who joined us! Together, we are contributing to the prevention and cure of cancer!…
Promotion and tenure season has started! First up - Dr. Inna Smalley shared her beautiful body of work on leptomeningeal disease. @MoffittNews @PatrickHwuMD

At the Lab Design Conference in Denver presenting the Moffitt Discovery and Innovation Center at SPEROS FL with my colleagues at DLR group/TKD. Thrilled to showcase our innovative design - Hope 3 ways - showcasing the integration of cancer biology, drug discovery, and…

Mariam shared her innovative research at #AACR2025 #MoffittAACR2025! Congratulations on winning an AACR Scholar in Training award, Mariam! @InnaSmalley
At #AACR25, Mariam Lotfy Khaled, PhD, from the @InnaSmalley lab joined Elsa Flores, PhD, (@LabElsaFlores) to discuss promising results that could lead to better outcomes for those with leptomeningeal disease. #MoffittAACR25
Fun times at #AACR2025 with my original lab partner @KYTsaiLab ! #MoffittAACR25

So proud to talk to my postdoc, Santanu Adhikary, about our collaboration with the Haura and Nguyen Labs to build bridges from basic science to bioengineering to the clinic @MoffittNews #MoffittAACR2025 #AACR2025 The goal is to build a greater understanding of mechanisms that…
At #AACR25, Santanu Adhikary, PhD, (@Santanu_Ads), joined Elsa Flores, PhD (@LabElsaFlores) to discuss how the P63-KRAS mutation drives treatment resistance in lung cancer. These insights could lead to more effective, targeted therapies. #MoffittAACR25
So great to highlight the research in Dr. Conor Lynch’s Dept of Tumor Microenvironment and Metastasis in the Division of Basic Science @MoffittNews ! He has a long history of performing Transdisciplinary research to tackle cancer metastasis. #MoffittAACR2025 #AACR2025
At #AACR25, Conor Lynch, PhD, joined Elsa Flores, PhD (@LabElsaFlores), to discuss new insights into the tumor microenvironment and metastasis, highlighting collaboration with the Integrated Mathematical Oncology team (@mathonco) to push the science forward. #MoffittAACR25
During #AACR25, Chang Jiang, PhD, (@ChangJiangLab) joins Elsa Flores, PhD, (@LabElsaFlores), to share insights into NRF2 expression in non-small cell lung cancer. #MoffittAACR25
While at #AACR25, Dr. Shahrzad Zamani (@zamanishahrz) joined me at the @MoffittNews booth to discuss her work in advancing cancer health equity. Dr. Zamani was also the recipient of a #AACRScholars in Training Award to attend @AACR! Congrats!
Live from #AACR25: Alexander Anderson, PhD, (@ara_anderson) leads the Adaptive Therapy from Board to Bench to Bedside and Back Again symposium. He shares how evolution-inspired treatment strategies like adaptive therapy can optimize drug use, delay resistance and improve outcomes…